The U.S. Preventive Services Task Force is discouraging ovarian cancer screening for asymptomatic women, saying it's ineffective and has a high incidence of false-positives and doesn't curb mortality rates.
UCLA Health rethought its approach to how it sends patients FIT kits, an at-home test patients can take to screen for colon cancer.
First Descents' mission is to provide outdoor experiences free for 18- to 39-year olds diagnosed with cancer. The weeklong and multiday adventure experiences include activities like whitewater kayaking, rock climbing and surfing.
Tempus, Eric Lefkofsky's startup that's tackling cancer treatment with big data, just got a major boost in the data department. The Chicago-based company and a partner are getting access to CancerLinQ, a database of treatment results developed by the American Society of Clinical Oncology.
Claims data can be a resource for identifying patients with unusual care needs.
Oncologists often feel pressure from breast cancer patients to provide longer and more costly treatments even when the patient is eligible for less aggressive options, a new study revealed.
With more people surviving cancer, programs to help them stay healthy after treatment are growing, but are still concentrated at large, expensive academic centers.
Tempus, Eric Lefkofsky's cancer-data company, is getting a $70 million boost from some familiar partners: New Enterprise Associates and Revolution Growth. The two Washington, D.C.-area venture funds led a new round of financing that brings the total outside investments in Tempus to $130 million.
Singleton oversaw the growth of the Falls Church, Va.-based system from $500 million to $3.3 billion in revenue. Recently, he was involved in efforts to bolster Inova's position as a national leader in precision medicine and cancer research.
The cancer community is deploying advanced-practice providers to help address a shortage of services. But integrating them into a practice isn't easy.
Plans are moving forward for a new cancer care facility in Detroit. A groundbreaking event takes place Tuesday for the Brigitte Harris Cancer Pavilion, which will be part of the Henry Ford Cancer Institute.
In an interview with Modern Healthcare this week, Soon-Shiong said his company's new cancer therapy gets to the root causes of the disease. He also said that recent reports questioning the success of his company's therapies are based on "ignorance," which he "ignores."